HomeBlood Disorders Information Center
Blood Disorders Information Center
Blood Disorders Information Center
Phlebotomy Fatigue? Comparing Low-Dose Ruxolitinib, Ropeginterferon and New Combination Trials for High-Need Polycythemia Vera
Few experiences scream living with polycythemia vera louder than the regular “blood-letting day.” While therapeutic phlebotomy quickly lowers hematocrit, high-need patients—those who cross 45...
Blood Disorders Information Center
Hematocrit Targets Are Changing: Is 45 Percent Still the Magic Number for Polycythemia Vera?
For more than a decade, the phrase “keep hematocrit below forty-five percent” has echoed through every consultation room where polycythemia vera is managed. That...
